trending Market Intelligence /marketintelligence/en/news-insights/trending/yauruo9fz0owjhmpsym-3a2 content esgSubNav
In This List

Biocure Technology director resigns; replacement named

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Biocure Technology director resigns; replacement named

Canada's Biocure Technology Inc. said Marco Nonni resigned as a director.

Nonni joined the company's board in April, and will continue working with Biocure Technology on a consulting basis.

The company appointed Hans Frykman to replace Nonni, effective Sept. 4.

Frykman is medical director at Neurocode Labs and UBC Diagnostic Services Lab.

Biocure Technology develops and commercializes biosimilar pharmaceutical products in South Korea.